Eli Lilly
4,600 hedge funds and large institutions have $941B invested in Eli Lilly in 2026 Q2 according to their latest regulatory filings, with 411 funds opening new positions, 2,197 increasing their positions, 1,470 reducing their positions, and 107 closing their positions.
284% more first-time investments, than exits
New positions opened: 411 | Existing positions closed: 107
49% more repeat investments, than reductions
Existing positions increased: 2,197 | Existing positions reduced: 1,470
32% more capital invested
Capital invested by funds: $714B → $941B (+$227B)
24% more funds holding in top 10
Funds holding in top 10: 378 → 468 (+90)
23% more call options, than puts
Call options by funds: $23.7B | Put options by funds: $19.2B
5% more funds holding
Funds holding: 4,373 → 4,600 (+227)
1.27% more ownership
Funds ownership: 82.16% → 83.43% (+1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.17B |
| 2 |
SG Americas Securities
New York
|
+$1.36B |
| 3 |
Goldman Sachs
New York
|
+$1.34B |
| 4 |
BlackRock
New York
|
+$1.18B |
| 5 |
Morgan Stanley
New York
|
+$806M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$3.84B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.48B |
| 3 |
Lilly Endowment
Indiananapolis,
Indiana
|
-$1.55B |
| 4 |
JP Morgan Chase
New York
|
-$1.12B |
| 5 |
DAM
Diamant Asset Management
Ridgefield,
Connecticut
|
-$1.09B |
LLY Hedge Fund Activity: Q2 2026 in Review
4,600 of the 8,277 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q2 2026, worth a combined $941B — up 32% from $714B a quarter earlier.
Buyers outnumbered sellers: 411 funds opened new LLY positions and 107 closed out — a net gain of 304 holders — while 2,197 added to existing stakes and 1,470 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $2.17B. The largest seller was Capital Research Global Investors, cutting an estimated $3.84B.
- 4,600 institutional investors held Eli Lilly (LLY) as of Q2 2026, up from 4,373 in Q1 2026.
- Funds reported $941B of Eli Lilly stock for Q2 2026, up 32% quarter-over-quarter.
- 411 funds opened new Eli Lilly positions in Q2 2026 and 107 closed out, a net change of +304 holders.
- The largest Eli Lilly buyer in Q2 2026 was Fidelity Investments, an estimated $2.17B added.
- The largest Eli Lilly seller in Q2 2026 was Capital Research Global Investors, an estimated $3.84B sold.
Based on aggregated 13F filings for Q2 2026.